In colloquial terms, ApoB isoforms contribute to two types of “bad cholesterol.” Heterozygosity for pathogenic mutations in APOB is the cause of 5% to –10% of cases of familial hypercholesterolemia (Beheshti et al. 2020). Here, APOB is linked to familial hypercholesterolemia.